Diabetes, Vol 40, Issue 2 190-196, Copyright © 1991 by American Diabetes Association

ARTICLES

Effect of diabetes and aging on carboxymethyllysine levels in human urine

KJ Knecht, JA Dunn, KF McFarland, DR McCance, TJ Lyons, SR Thorpe and JW Baynes
Department of Chemistry, University of South Carolina, Columbia 29208.

Carboxymethyllysine (CML) has been identified as a modified amino acid that accumulates with age in human lens proteins and collagen. CML may be formed by oxidation of fructoselysine (FL), the Amadori adduct formed on nonenzymatic glycosylation of lysine residues in protein, or by reaction of ascorbate with protein under autoxidizing conditions. We proposed that measurements of tissue and urinary CML may be useful as indices of oxidative stress or damage to proteins in vivo. To determine the extent to which oxidation of nonenzymatically glycosylated proteins contributes to urinary CML, we measured the urinary concentrations of FL and CML in diabetic (n = 26) and control (n = 28) patients. The urinary concentration of FL correlated strongly with HbA1 measurements and was significantly higher in diabetic compared with control samples (9.2 +/- 6.5 and 4.0 +/- 2.8 micrograms/mg creatinine, respectively; P less than 0.0001). There was also a strong correlation between the concentrations of CML and FL in both diabetic and control urine (r = 0.67, P less than 0.0001) but only a weakly significant increase in the CML concentration in diabetic compared with control urine (1.2 +/- 0.5 and 1.0 +/- 0.3 micrograms/mg creatinine, respectively; P = 0.05). The molar ratio of CML to FL was significantly lower in diabetic compared with control patients (0.25 +/- 0.12 and 0.43 +/- 0.16, respectively; P less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. J. Hulbert, R. Pamplona, R. Buffenstein, and W. A. Buttemer Life and Death: Metabolic Rate, Membrane Composition, and Life Span of Animals Physiol Rev, October 1, 2007; 87(4): 1175 - 1213. [Abstract] [Full Text] [PDF]

				A. Sanz, P. Caro, V. Ayala, M. Portero-Otin, R. Pamplona, and G. Barja Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins FASEB J, June 1, 2006; 20(8): 1064 - 1073. [Abstract] [Full Text] [PDF]

				A. S. Januszewski, N. L. Alderson, A. J. Jenkins, S. R. Thorpe, and J. W. Baynes Chemical modification of proteins during peroxidation of phospholipids J. Lipid Res., July 1, 2005; 46(7): 1440 - 1449. [Abstract] [Full Text] [PDF]

				T. Teerlink, R. Barto, H. J. ten Brink, and C. G. Schalkwijk Measurement of N{epsilon}-(Carboxymethyl)lysine and N{epsilon}-(Carboxyethyl)lysine in Human Plasma Protein by Stable-Isotope-Dilution Tandem Mass Spectrometry Clin. Chem., July 1, 2004; 50(7): 1222 - 1228. [Abstract] [Full Text] [PDF]

				M. M. Anderson and J. W. Heinecke Production of N{varepsilon}-(Carboxymethyl)Lysine Is Impaired in Mice Deficient in NADPH Oxidase: A Role for Phagocyte-Derived Oxidants in the Formation of Advanced Glycation End Products During Inflammation Diabetes, August 1, 2003; 52(8): 2137 - 2143. [Abstract] [Full Text] [PDF]

				R. Nagai, Y. Unno, M. C. Hayashi, S. Masuda, F. Hayase, N. Kinae, and S. Horiuchi Peroxynitrite Induces Formation of N{varepsilon}-(Carboxymethyl)Lysine by the Cleavage of Amadori Product and Generation of Glucosone and Glyoxal From Glucose: Novel Pathways for Protein Modification by Peroxynitrite Diabetes, September 1, 2002; 51(9): 2833 - 2839. [Abstract] [Full Text] [PDF]

				T. MIYATA, Y. UEDA, K. ASAHI, Y. IZUHARA, R. INAGI, A. SAITO, C. VAN YPERSELE DE STRIHOU, and K. KUROKAWA Mechanism of the Inhibitory Effect of OPB-9195 [({+/-})-2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide] on Advanced Glycation End Product and Advanced Lipoxidation End Product Formation J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1719 - 1725. [Abstract] [Full Text]

				R. Pamplona, M. Portero-Otín, D. Riba, J. R. Requena, S. R. Thorpe, M. López-Torres, and G. Barja Low Fatty Acid Unsaturation: A Mechanism for Lowered Lipoperoxidative Modification of Tissue Proteins in Mammalian Species With Long Life Spans J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2000; 55(6): 286B - 291. [Abstract] [Full Text]

				H. H. F. Refsgaard, L. Tsai, and E. R. Stadtman Modifications of proteins by polyunsaturated fatty acid peroxidation products PNAS, January 18, 2000; 97(2): 611 - 616. [Abstract] [Full Text] [PDF]

				T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, et al. Nepsilon -(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression J. Biol. Chem., October 29, 1999; 274(44): 31740 - 31749. [Abstract] [Full Text] [PDF]

				J. R. Requena, M. U. Ahmed, C. W. Fountain, T. P. Degenhardt, S. Reddy, C. Perez, T. J. Lyons, A. J. Jenkins, J. W. Baynes, and S. R. Thorpe Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo J. Biol. Chem., July 11, 1997; 272(28): 17473 - 17479. [Abstract] [Full Text] [PDF]

				M.-X. Fu, J.ús R. Requena, A. J. Jenkins, T. J. Lyons, J. W. Baynes, and S. R. Thorpe The Advanced Glycation End Product, N[IMAGE]-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions J. Biol. Chem., April 26, 1996; 271(17): 9982 - 9986. [Abstract] [Full Text] [PDF]

				J. R. Requena, C.-C. Chao, R. L. Levine, and E. R. Stadtman Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins PNAS, January 2, 2001; 98(1): 69 - 74. [Abstract] [Full Text] [PDF]